603168 莎普爱思
午间休市 04-10 11:29:55
资讯
新帖
简况
每周股票复盘：莎普爱思（603168）签署7100万元专利转让合同
证券之星 · 04-05
每周股票复盘：莎普爱思（603168）签署7100万元专利转让合同
持续打击医保药品领域违法违规问题；中国首个原创核药获批
21世纪经济报道 · 04-03
持续打击医保药品领域违法违规问题；中国首个原创核药获批
莎普爱思(603168.SH)与温医大眼视光医院等签署技术转让合同
智通财经 · 04-02
莎普爱思(603168.SH)与温医大眼视光医院等签署技术转让合同
再次延期回复！莎普爱思5.28亿元收购上海勤礼引监管火速问询：高估值、高对赌、低现金、缺信披四大疑点待解
蓝鲸财经 · 03-31
再次延期回复！莎普爱思5.28亿元收购上海勤礼引监管火速问询：高估值、高对赌、低现金、缺信披四大疑点待解
每周股票复盘：莎普爱思（603168）收投服中心建议函质疑收购
证券之星 · 03-29
每周股票复盘：莎普爱思（603168）收投服中心建议函质疑收购
股市必读：新发布《浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告》
证券之星 · 03-26
股市必读：新发布《浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告》
莎普爱思拟溢价24倍收购关联方旗下医院引质疑，中证投服中心追问几大疑点
每日经济新闻 · 03-25
莎普爱思拟溢价24倍收购关联方旗下医院引质疑，中证投服中心追问几大疑点
莎普爱思延期回复问询函 股东发函质疑天伦医院盈利情况
新京报 · 03-25
莎普爱思延期回复问询函 股东发函质疑天伦医院盈利情况
股市必读：新发布《浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告》
证券之星 · 03-25
股市必读：新发布《浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告》
股市必读：莎普爱思（603168）3月20日收盘跌7.9%，主力净流出133.98万元
证券之星 · 03-23
股市必读：莎普爱思（603168）3月20日收盘跌7.9%，主力净流出133.98万元
每周股票复盘：莎普爱思（603168）拟5.28亿收购上海勤礼100%股权
证券之星 · 03-22
每周股票复盘：莎普爱思（603168）拟5.28亿收购上海勤礼100%股权
莎普爱思24倍高溢价收购背后：莆田系关联腾挪资本局？此前高溢价收购标的已减值暴雷
新浪证券 · 03-20
莎普爱思24倍高溢价收购背后：莆田系关联腾挪资本局？此前高溢价收购标的已减值暴雷
溢价24倍收购关联方医院，莎普爱思“银发经济”布局遭监管火速问询
新浪证券 · 03-20
溢价24倍收购关联方医院，莎普爱思“银发经济”布局遭监管火速问询
两次收购业绩“变脸”仍24倍高溢价并购实控人资产，莎普爱思林氏兄弟资产腾挪遭交易所连夜发函拷问
蓝鲸财经 · 03-18
两次收购业绩“变脸”仍24倍高溢价并购实控人资产，莎普爱思林氏兄弟资产腾挪遭交易所连夜发函拷问
3月18日莎普爱思（603168）涨停分析：医院收购、眼科医疗驱动
证券之星 · 03-18
3月18日莎普爱思（603168）涨停分析：医院收购、眼科医疗驱动
莎普爱思最新公告：拟5.28亿元收购上海勤礼100%股权
证券之星 · 03-17
莎普爱思最新公告：拟5.28亿元收购上海勤礼100%股权
每周股票复盘：莎普爱思（603168）2025年预亏最高3.42亿
证券之星 · 02-01
每周股票复盘：莎普爱思（603168）2025年预亏最高3.42亿
莎普爱思（603168）披露2025年度业绩预亏公告，1月29日股价上涨0.13%
证券之星 · 01-29
莎普爱思（603168）披露2025年度业绩预亏公告，1月29日股价上涨0.13%
每周股票复盘：莎普爱思（603168）预计2025年净利为负
证券之星 · 01-18
每周股票复盘：莎普爱思（603168）预计2025年净利为负
莎普爱思最新公告：二氟尼柳片通过仿制药一致性评价
证券之星 · 01-15
莎普爱思最新公告：二氟尼柳片通过仿制药一致性评价
加载更多
公司概况
公司名称：
浙江莎普爱思药业股份有限公司
所属行业：
医药制造业
上市日期：
2014-07-02
主营业务：
浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是滴眼液、大输液、头孢克肟、诊疗服务。公司于2024年被授予科技进步先进单位及创新赋能奖荣誉。
发行价格：
21.85
{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":6.96,"timestamp":1775791795000,"preClose":6.79,"halted":0,"volume":7270750,"delay":0,"changeRate":0.025,"floatShares":373000000,"shares":374000000,"eps":-0.1739,"marketStatus":"午间休市","change":0.17,"latestTime":"04-10 11:29:55","open":6.92,"high":7.01,"low":6.74,"amount":50148600,"amplitude":0.0398,"askPrice":6.96,"askSize":21,"bidPrice":6.95,"bidSize":154,"shortable":0,"etf":0,"ttmEps":-0.1739,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775797200000},"marketStatusCode":3,"adr":0,"adjPreClose":6.79,"symbolType":"stock","openAndCloseTimeList":[[1775784600000,1775791800000],[1775797200000,1775804400000]],"highLimit":7.47,"lowLimit":6.11,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":374126505,"isCdr":false,"pbRate":1.57,"roa":"--","roe":"1.72%","epsLYR":-0.33,"committee":-0.046926,"marketValue":2604000000,"turnoverRate":0.0195,"status":0,"floatMarketCap":2593000000},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2625619285","title":"每周股票复盘：莎普爱思（603168）签署7100万元专利转让合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2625619285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625619285?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:23","pubTimestamp":1775330590,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，莎普爱思报收于6.81元，较上周的6.93元下跌1.73%。本周，莎普爱思3月31日盘中最高价报7.22元。本周关注点公司公告汇总：莎普爱思签署7100万元专利转让合同及未来销售提成。公司公告汇总浙江莎普爱思药业股份有限公司于2026年3月17日收到上海证券交易所下发的《关于公司向关联方购买资产相关事项的问询函》，要求在5个交易日内回复。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624313635","title":"持续打击医保药品领域违法违规问题；中国首个原创核药获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2624313635","media":"21世纪经济报道","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624313635?lang=zh_cn&edition=full","pubTime":"2026-04-03 08:02","pubTimestamp":1775174556,"startTime":"0","endTime":"0","summary":"政策动向国家医保局持续开展打击医保药品领域违法违规问题专项行动近日国家医保局办公室印发《关于深入开展打击医保药品领域违法违规问题专项行动的通知》，对持续打击倒卖医保“回流药”等违法违规问题进行专门部署。《通知》要求，自2026年4月起，以药品追溯码疑点线索核查为抓手，在全国范围内继续深入开展打击医保药品领域违法违规问题专项行动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033694126468.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033694126468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","09688","BK1588","LU2488822045.USD","603168","BK4080","AGIX","BK0239","CHAT","06978","BK1161","688520","BK1574","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624579828","title":"莎普爱思(603168.SH)与温医大眼视光医院等签署技术转让合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2624579828","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624579828?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:54","pubTimestamp":1775116460,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)公告，公司与温州医科大学附属眼视光医院(简称“温医大眼视光医院”)、周翔天教授签署了《技术转让(专利权)合同》，温医大眼视光医院将其名(包括海外申请对应的中译名)为“一种采用SPAS-26021治疗近视的方法”的10项合作产品核心专利、合作产品专有技术及相关权益全部转让给公司，转让价格为7100万元以及合作产品上市后的销售提成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397307","title":"再次延期回复！莎普爱思5.28亿元收购上海勤礼引监管火速问询：高估值、高对赌、低现金、缺信披四大疑点待解","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397307","media":"蓝鲸财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623397307?lang=zh_cn&edition=full","pubTime":"2026-03-31 17:33","pubTimestamp":1774949614,"startTime":"0","endTime":"0","summary":"3月17日，莎普爱思披露拟以5.28亿元现金收购控股股东养和实业及一致行动人谊和医疗持有的上海勤礼100%股权，进而间接取得上海天伦医院控制权。公告次日，上交所即下发问询函，直指本次交易估值畸高、业绩承诺缺乏支撑、资金来源存疑等核心问题。公司两次申请延期回复，截至4月1日仍未完成正式答复。截至2025年三季度末，莎普爱思货币资金余额为1.01亿元，交易性金融资产为1.22亿元，合计2.23亿元，远低于首两期合计约3.70亿元的付款义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774949359502091663","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533380","title":"每周股票复盘：莎普爱思（603168）收投服中心建议函质疑收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533380","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623533380?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:08","pubTimestamp":1774728491,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，莎普爱思报收于6.93元，较上周的6.88元上涨0.73%。本周，莎普爱思3月27日盘中最高价报6.94元。浙江莎普爱思药业股份有限公司于2026年3月24日收到中证中小投资者服务中心《股东建议函》，针对公司拟以5.28亿元现金收购控股股东及其一致行动人持有的上海勤礼实业有限公司100%股权事项提出质疑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622093310","title":"股市必读：新发布《浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2622093310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622093310?lang=zh_cn&edition=full","pubTime":"2026-03-26 02:27","pubTimestamp":1774463231,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告浙江莎普爱思药业股份有限公司于2026年3月17日收到上海证券交易所下发的《关于向关联方购买资产相关事项的问询函》，要求在5个交易日内书面回复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600002654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622878045","title":"莎普爱思拟溢价24倍收购关联方旗下医院引质疑，中证投服中心追问几大疑点","url":"https://stock-news.laohu8.com/highlight/detail?id=2622878045","media":"每日经济新闻","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622878045?lang=zh_cn&edition=full","pubTime":"2026-03-25 10:21","pubTimestamp":1774405260,"startTime":"0","endTime":"0","summary":" 近期，一笔溢价高达24倍的关联收购，将莎普爱思推上了风口浪尖。 3月24日，莎普爱思公告称，公司曾于今年3月17日收到上海证券交易所关于公司向关联方购买资产相关事项的问询函。 同日，莎普爱思还披露其收到中证中小投资者服务中心发来的《股东建议函》。中证投服中心称，对标的公司近两年经营业绩大幅增长的原因、本次交易估值的合理性尚存疑问，现依法行使股东建议权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-03-25/doc-inhseiya6903716.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-25/doc-inhseiya6903716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622010148","title":"莎普爱思延期回复问询函 股东发函质疑天伦医院盈利情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2622010148","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622010148?lang=zh_cn&edition=full","pubTime":"2026-03-25 09:16","pubTimestamp":1774401360,"startTime":"0","endTime":"0","summary":"收购完成后，公司将间接持有天伦医院100%股权。同日，公司因相关收购收到上交所问询函。上交所在问询函中指出，莎普爱思前期已向控股股东收购泰州妇产医院、青岛视康眼科医院，但两家医院资产在业绩承诺期满后均出现业绩下滑，形成的商誉目前均面临减值风险，要求公司对业绩承诺可实现性作出说明。宣布延期回复问询函当日，莎普爱思同时收到中证中小投资者服务中心发来的《股东建议函》。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2026/03/24/5700572190156598334.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/03/24/5700572190156598334.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1774364469129794.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1774364469129794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622092070","title":"股市必读：新发布《浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2622092070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622092070?lang=zh_cn&edition=full","pubTime":"2026-03-25 02:03","pubTimestamp":1774375399,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江莎普爱思药业股份有限公司关于延期回复上海证券交易所问询函的公告浙江莎普爱思药业股份有限公司于2026年3月17日收到上海证券交易所下发的《关于向关联方购买资产相关事项的问询函》，要求在5个交易日内书面回复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500003498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621749136","title":"股市必读：莎普爱思（603168）3月20日收盘跌7.9%，主力净流出133.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621749136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621749136?lang=zh_cn&edition=full","pubTime":"2026-03-23 04:18","pubTimestamp":1774210693,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，莎普爱思报收于6.88元，下跌7.9%，换手率7.74%，成交量28.84万手，成交额2.05亿元。交易信息汇总莎普爱思3月20日收盘价为6.88元，跌幅7.9%，当日成交金额2883.73万元。该股票已连续两个交易日下跌。在前10个交易日内，主力资金累计净流入5899.39万元，同期股价累计下跌4.56%。资金流向3月20日，莎普爱思主力资金净流出133.98万元，占总成交额的0.66%；游资资金净流入15.31万元，占总成交额0.07%；散户资金净流入118.67万元，占总成交额0.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300001661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621791805","title":"每周股票复盘：莎普爱思（603168）拟5.28亿收购上海勤礼100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2621791805","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621791805?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:25","pubTimestamp":1774121113,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，莎普爱思报收于6.88元，较上周的7.24元下跌4.97%。本周，莎普爱思3月19日盘中最高价报7.85元。本周关注点公司公告汇总：莎普爱思拟以5.28亿元现金收购上海勤礼实业有限公司100%股权。公司公告汇总莎普爱思第六届董事会第十二次会议审议通过《关于公司收购股权暨关联交易的议案》，拟以现金52,800.00万元收购上海谊和医疗管理有限公司、上海养和实业有限公司持有的上海勤礼实业有限公司100%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620731882","title":"莎普爱思24倍高溢价收购背后：莆田系关联腾挪资本局？此前高溢价收购标的已减值暴雷","url":"https://stock-news.laohu8.com/highlight/detail?id=2620731882","media":"新浪证券","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620731882?lang=zh_cn&edition=full","pubTime":"2026-03-20 21:21","pubTimestamp":1774012860,"startTime":"0","endTime":"0","summary":" 核心观点：莎普爱思以24倍超高溢价现金收购实控人体外资产，在公司账面资金并不宽裕背景下，上市公司是否可能被透支？ 近日，莎普爱思高溢价收购实控人体外资产引发市场关注。 莎普爱思此次收购有两大信息值得关注，其一，莎普爱思此次收购标的为控股股东体外标的；其二，此次为高溢价现金收购，溢价率高达24倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-03-20/doc-inhrrzuq3835384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620789509","title":"溢价24倍收购关联方医院，莎普爱思“银发经济”布局遭监管火速问询","url":"https://stock-news.laohu8.com/highlight/detail?id=2620789509","media":"新浪证券","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620789509?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:49","pubTimestamp":1773996540,"startTime":"0","endTime":"0","summary":"一笔溢价超过24倍的关联收购，让正处于业绩亏损中的莎普爱思再次成为市场焦点。近日，公司公告拟以5.28亿元现金收购控股股东旗下上海勤礼100%股权，从而间接持有上海天伦医院全部股权。然而，交易的高溢价、高业绩承诺以及公司自身的资金压力，迅速引来了上交所的问询函，要求公司说明交易公允性、业绩承诺可实现性及资金来源等问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-03-20/doc-inhrrrer7994009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620254895","title":"两次收购业绩“变脸”仍24倍高溢价并购实控人资产，莎普爱思林氏兄弟资产腾挪遭交易所连夜发函拷问","url":"https://stock-news.laohu8.com/highlight/detail?id=2620254895","media":"蓝鲸财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620254895?lang=zh_cn&edition=full","pubTime":"2026-03-18 21:54","pubTimestamp":1773842065,"startTime":"0","endTime":"0","summary":"据公告，本次收购的标的公司上海勤礼成立于2022年7月，法定代表人为林弘立，其核心资产为全资子公司天伦医院。此外，莎普爱思明确指出，本次收购也是实控人履行解决同业竞争承诺的重要举措。天伦医院为公司实控人林弘立、林弘远兄弟控制的医疗服务企业，与莎普爱思全资子公司泰州市妇女儿童医院存在潜在同业竞争关系，而林弘立、林弘远兄弟此前已作出相关承诺，将逐步解决上述同业竞争问题，本次收购正是履行该承诺的具体行动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1773838020724483573","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620388252","title":"3月18日莎普爱思（603168）涨停分析：医院收购、眼科医疗驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2620388252","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620388252?lang=zh_cn&edition=full","pubTime":"2026-03-18 15:32","pubTimestamp":1773819121,"startTime":"0","endTime":"0","summary":"证券之星消息，莎普爱思3月18日涨停收盘，收盘价7.8元。今日莎普爱思涨停的可能因素有：拟以5.28亿元现金收购上海勤礼100%股权，间接全资控股天伦医院，强化“药+医”双轮驱动战略；公司眼科核心产品苄达赖氨酸滴眼液市场份额领先，OTC渠道优势稳固；青岛视康医院新增眼底病专科并开展手术，医疗服务能力持续升级；2025年半年报显示归母净利润2186.29万元，同比扭亏为盈，基本面显著改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800021098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620440385","title":"莎普爱思最新公告：拟5.28亿元收购上海勤礼100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440385","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620440385?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:10","pubTimestamp":1773738610,"startTime":"0","endTime":"0","summary":"莎普爱思(603168.SH)公告称，公司拟以现金5.28亿元收购控股股东养和实业及一致行动人谊和医疗持有的上海勤礼100%股权。本次交易完成后，公司将间接持有上海天伦医院100%股权。交易旨在解决与实际控制人间的同业竞争问题，并增强公司医疗服务板块的盈利能力。海勤礼全资子公司天伦医院是按照全科医院标准创建，集医疗、预防、保健为一体的现代化综合医院，科室齐全，盈利能力突出。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700029311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608772460","title":"每周股票复盘：莎普爱思（603168）2025年预亏最高3.42亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2608772460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608772460?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:18","pubTimestamp":1769887092,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，莎普爱思报收于7.35元，较上周的7.79元下跌5.65%。本周，莎普爱思1月26日盘中最高价报7.83元。本周关注点业绩披露要点：莎普爱思预计2025年扣非净利润亏损2.28亿元至3.42亿元。公司公告汇总：莎普爱思因商誉减值预计2025年度归母净利润亏损2.128亿元至3.192亿元。公司公告汇总浙江莎普爱思药业股份有限公司预计2025年度实现归属于母公司所有者的净利润为-31,920.00万元到-21,280.00万元，扣除非经常性损益后的净利润为-34,200.00万元到-22,800.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607397340","title":"莎普爱思（603168）披露2025年度业绩预亏公告，1月29日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607397340","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607397340?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:25","pubTimestamp":1769700315,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，莎普爱思报收于7.53元，较前一交易日上涨0.13%，最新总市值为28.17亿元。该股当日开盘7.5元，最高7.6元，最低7.4元，成交额达5772.27万元，换手率为2.06%。近日，浙江莎普爱思药业股份有限公司发布2025年度业绩预亏公告。公告显示，公司预计2025年度实现归属于母公司所有者的净利润为-31,920.00万元到-21,280.00万元，扣除非经常性损益后的净利润为-34,200.00万元到-22,800.00万元。本期业绩预告未经注册会计师审计，数据为初步核算结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604258759","title":"每周股票复盘：莎普爱思（603168）预计2025年净利为负","url":"https://stock-news.laohu8.com/highlight/detail?id=2604258759","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604258759?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:34","pubTimestamp":1768678449,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，莎普爱思报收于7.53元，较上周的7.69元下跌2.08%。本周，莎普爱思1月13日盘中最高价报7.84元。业绩披露要点莎普爱思发布业绩预告，预计2025年全年归属净利润为负值。公司公告汇总莎普爱思2025年度业绩预亏的提示性公告浙江莎普爱思药业股份有限公司预计2025年度归属于母公司所有者的净利润为负值，主要由于需计提商誉减值准备所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603674699","title":"莎普爱思最新公告：二氟尼柳片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2603674699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603674699?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:43","pubTimestamp":1768463008,"startTime":"0","endTime":"0","summary":"莎普爱思(603168.SH)公告称，公司收到国家药品监督管理局核发的二氟尼柳片的《药品补充申请批准通知书》，同意批准增加0.5g规格的补充申请，视同通过仿制药质量和疗效一致性评价。该药品适用于类风湿性关节炎、骨关节炎等，累计研发投入约为714.92万元。此次获得批准进一步丰富了公司产品线，但药品生产和销售受政策、市场等多因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500020102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775793547150,"stockEarnings":[{"period":"1week","weight":-0.0396},{"period":"1month","weight":-0.0686},{"period":"3month","weight":-0.117},{"period":"6month","weight":-0.1182},{"period":"1year","weight":0.0847},{"period":"ytd","weight":-0.0774}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0381},{"period":"3month","weight":-0.0374},{"period":"6month","weight":0.0177},{"period":"1year","weight":0.2446},{"period":"ytd","weight":-0.0007}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"28285人(较上一季度增加2.43%)","perCapita":"13170股","listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","registeredCapital":"37412万元","survey":" 浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是滴眼液、大输液、头孢克肟、诊疗服务。公司于2024年被授予科技进步先进单位及创新赋能奖荣誉。","listedPrice":21.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}